NCCN GUIDELINES® INSIGHTS Cervical Cancer, Version 1.2024

Nadeem R. Abu-Rustum, Catheryn M. Yashar, Rebecca Arend, Emma Barber, Kristin Bradley, Rebecca Brooks, Susana M. Campos, Junzo Chino, Hye Sook Chon, Marta Ann Crispens, Shari Damast, Christine M. Fisher, Peter Frederick, David K. Gaffney, Stephanie Gaillard, Robert Giuntoli, Scott Glaser, Jordan Holmes, Brooke E. Howitt, Jayanthi LeaGina Mantia-Smaldone, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Mirna Podoll, Kerry Rodabaugh, Ritu Salani, John Schorge, Jean Siedel, Rachel Sisodia, Pamela Soliman, Stefanie Ueda, Renata Urban, Emily Wyse, Nicole R. McMillian, Shaili Aggarwal, Sara Espinosa

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.

Original languageEnglish
Pages (from-to)1224-1233
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume21
Issue number12
DOIs
StatePublished - Dec 2023

Fingerprint

Dive into the research topics of 'NCCN GUIDELINES® INSIGHTS Cervical Cancer, Version 1.2024'. Together they form a unique fingerprint.

Cite this